ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. The Lancet HIV Commission on ageing and…

The Lancet HIV Commission on ageing and HIV: a global perspective

The Lancet HIV·July 27
ImmunologyInfectious DiseasesPractice changingFrailtyHIV InfectionMultimorbidityCommission Report / Systematic ReviewAntiretroviral TherapyOlder Adult

Summary

View source

What was studied

This Lancet HIV Commission examined the global landscape of ageing with HIV, evaluating epidemiological trends, clinical complexities, and health system responses for people ageing with HIV across diverse global settings.

Key findings

The Commission highlights that a growing proportion of people living with HIV are now older adults, facing multimorbidity, polypharmacy, frailty, and social isolation at higher rates than HIV-negative peers, with health systems largely unprepared to address these compounding needs.

Study limitations

As a Commission report, conclusions are based on synthesis of existing evidence rather than original primary data; the global scope may mask significant regional heterogeneity, particularly in low- and middle-income countries where data on older people with HIV remain sparse.

Clinical implications

Clinicians should routinely screen older people with HIV for frailty, multimorbidity, and polypharmacy, integrating geriatric principles into HIV care. Health systems need dedicated models of care that address the intersecting challenges of ageing and HIV across all income settings.

Caveats

  • Level of evidence assigned as '3' reflects expert consensus/narrative review typical of commission reports; this may need revision pending full-text review.
  • Study design classification as 'Commission Report / Systematic Review' is inferred from the 'Commission' label; the exact methodology (e.g., whether a formal systematic review was conducted) is unconfirmed.
  • The full text was not directly available; summary is based on the paper's metadata, title, and standard scope of Lancet Commission reports — specific numerical findings, sample sizes, and regional breakdowns could not be verified.

Related Questions

Explore related topics

What are the best screening tools for frailty in older adults living with HIV?How should polypharmacy be managed in older people on antiretroviral therapy?What integrated care models exist for ageing people living with HIV in low- and middle-income countries?

Publication Details

Year
2026
Journal
The Lancet HIV
Source
View article
Keep scrolling
More content below.
Up Next